Abstract. The differentiation of homologous chromosomes as well as their parental origin can presently be conducted and determined exclusively by molecular genetic methods using microsatellite or SNP analysis. Only in exceptional cases is a distinction on a single-cell level possible, e.g. due to variations within the heterochromatic regions of chromosomes 1, 9, 16 and Y or the p-arms of the acrocentric chromosomes. In the absence of such polymorphisms, an individual distinction of the homologous chromosomes is not currently possible. Consequently, various questions of scientific and diagnostic relevance are unable to be answered. Based on the recently detected large-scale copy-number variations (LCV) or copynumber polymorphisms (CNP) spanning up to several megabase pairs of DNA, in this study, a molecular cytogenetic technique for the inter-individual differentiation of homologous chromosomes called parental-origin-determination fluorescence in situ hybridization (pod-FISH) is presented. All human chromosomes were covered with 225 LCVand/or CNP-specific BAC probes, and one-to five-color chromosome-specific pod-FISH sets were created, evaluated and optimized. We demonstrated that pod-FISH is suitable for single-cell analysis of uniparental disomy (UDP) in clinical cases such as Prader-Willi syndrome caused by maternal UPD. A rare clinical case with a mosaic form of a genome-wide isodisomy was used to determine the detection limits of pod-FISH. Additionally we analyzed the informativeness of conventional microsatellite analysis for the first time and compared the results to pod-FISH. With this new possibility to study the parental origin of individual human chromosomes on a single-cell level, new doors for diagnostic and basic research are opened.
Introduction
Considering the molecular genetic level of the genome, there is a genetic variation, up to 0.1% of the DNA sequence, between any two human individuals. These differences include single-nucleotide polymorphisms (SNP), which appear in every thousand base pairs on average and are located in or outside coding regions (1) , small insertiondeletion polymorphisms (INDEL) and non-coding polymorphisms like mini-and microsatellites (2) . Although these DNA variations affect alleles on homologous chromosomes they cannot be used to distinguish chromosomes on a singlecell level. Differentiation of the parental origin of homologous sequences is therefore currently possible only by molecular genetic methods, such as using DNA isolated from a mixture of many different single cells, followed by approaches such as microsatellite analysis (3) or methylationsensitive PCR (4) . In contrast, conventional cytogenetics allows a differentiation with respect to maternal or paternal origin on a single-cell level, but only for a specific subset of human chromosomes and only in exceptional cases (5) . This can be conducted based on size variations of the heterochromatic regions of chromosomes 1, 9, 16 and Y, or of the short arms of acrocentric chromosomes, inversion polymorphisms for chromosomes 2 and 9 (6,7) or even less frequently, if different dimensions of centromeric heterochromatin (cenh+ variants) are observed (8) . In the absence of such microscopically visible polymorphisms a discrimination between human homologous chromosomes is impossible on a singlecell level (Fig. 1) . Consequently, a number of questions of scientific and diagnostic relevance remain unanswered.
The picture of the human genome was remarkably changed and extended by a new kind of polymorphism discovered three years ago, called large-scale copy-number variations (LCV) (9) or copy-number polymorphisms (CNP) (10) . These variations were found by DNA microarray technology and include hundreds of previously undetected structural variants in the human genome such as deletions, gains and inversions. Surprisingly, LCV/CNP can have sizes of ten to several hundred thousand base pairs and are located in euchromatic regions all over the genome. It is expected that these large scale variations can directly affect gene dosage and therefore contribute essentially to phenotypic variation in humans (1) . Currently (July 2007), there are 3643 reported structural variations (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) that have been collected in the database of genomic variants (http://projects.tcag.ca/ variation/).
Concerning the huge size of these newly described structural variants it is currently possible to connect the molecular genetic level of DNA polymorphisms with microscopically visible homologous chromosomes. Moreover, they may be used for distinguishing cytogenetically identical homologous chromosomes. Utilizing this advantage, we describe for the first time the discrimination of homologous human chromosomes based on DNA sequence polymorphisms. This was achieved by a special fluorescence in situ hybridization (FISH) technique; the so-called parental-origindetermination FISH (pod-FISH). The usefulness and feasibility of this new approach is demonstrated, its efficiency will be compared to conventional microsatellite analysis and prospects for future applications are discussed.
Materials and methods
Cells. Molecular cytogenetic studies were performed on peripheral blood lymphocytes. The evaluation of pod-FISH probes was performed on chromosomes from one healthy proband. Chromosome-specific pod-FISH sets for chromosomes 1, 9 and 16 were tested on five probands showing a heterochromatin enlargement in one homologous chromosome (as described above). pod-FISH sets for all chromosomes were tested on a rare clinical case of a mosaic form of a genome-wide isodisomy. Chromosome preparations were conducted according to standard techniques (21).
Molecular cytogenetics. Two hundred and twenty-five polymorphic regions were selected which had a size >150 kb, that were reported in more than one person or study and that were reported for loss from the database of genomic variants (http://projects. tcag.ca/variation/). BAC clones were purchased from the Children's Hospital Oakland Research Institute (CHORI), Oakland, CA, USA or kindly provided by the Sanger Center. A list of all BAC clones is provided in Table I . All BAC DNA was isolated, PCR-amplified and labeled as described (22) . Single and multicolor fluorescence in situ hybridization (FISH) techniques were performed according to published protocols (22, 23) .
Microsatellite analysis. Microsatellite studies were conducted in 182 UPD analyses on the basis of 299 different microsatellites (data not shown). Therefore genomic DNA was isolated from the lymphocytes of the patients, and PCR was performed as described in (24) .
Results and discussion

Selection of probes and analysis of pod-FISH signals.
Two hundred and twenty-five of over 3643 polymorphic loci were selected from the database of genomic variants. These were chosen, as they were reported to be frequently deleted and Table I . Continued. Table I . Continued. Table I . Continued. -17  q12  259  RP11-586K24  AQ333429  33551  33602  17  q21.2  261  RP11-29C11  B87496  36749  36924  17  q21  263  RP11-243L6  AQ488523  41572  41734  17 q23 
----------------------------------------------------------------------------------------------------
Chr, chromosome; Band, cytogenetic band; VL, variation locus; BAC, AC-accession code; Start kb and End kb, start and end of the BAC clone on the chromosome. The BAC clones that showed a polymorphism on the tested female subject are indicated in bold print.
a Only available on NCBI 35; b only available on the database of genomic variants.
-
partially or completely lost. In molecular cytogenetics a loss, e.g. in microdeletion syndromes, is unambiguously detected, while a small gain of copy number, like in microduplication syndromes (23) , is much harder to distinguish. Since there are no studies available on LCV/CNP frequency in the general population only regions were taken into account, that were observed in more than one person or study. Additionally, these regions needed to have a size >150 kb in order to be detectable in FISH. According to these requirements we selected 225 BAC clones from the NCBI database (http://www.ncbi.nlm. nih.gov/) as listed in Table I . All probes were initially tested on chromosomes from one clinically healthy person. Here, the overall frequency of pod-FISH detectable polymorphisms was 29.3%; 66 of 225 regions showed a complete loss or a microscopically detectable decrease in fluorescence intensity in one of the two homologous chromosome (BAC clones in bold print; Table I ).
The evaluation of pod-FISH probes is able to be performed in several ways: i) by naked eye using a fluorescence microscope ( Fig. 2A) , ii) by analyzing fluorescence profiles with an appropriate software ( Fig. 2B and C; Fig. 3A ) and iii) by measuring signal intensity and area with a software that was previously proven suitable for measuring FISH intensity signal. For our purposes, the freeware SCION (http:www. scioncorp.com) was applied (25) (Fig. 3B) .
In order to observe real signal intensity differences caused by LCV/CNP polymorphisms and not variations of the FISH method itself, we analyzed 10-25 metaphase spreads per hybridization to obtain a semi-statistical mean value.
Creation and evaluation of pod-FISH sets. As it is useful to work with more than one polymorphic BAC probe simultaneously, chromosome-specific pod-FISH sets based on 5 different fluorochromes were created. For larger chromosomes such as 1, 2, 3, 4, 6, 9 and X, it was more convenient to generate chromosome arm-specific pod-FISH sets for an easier analysis and to prevent double labeling. A corresponding overview of all 31 human pod-FISH sets is provided in Fig. 5 . To test the reliability and the reproducibility of the pod-FISH approach in distinguishing homologous chromosomes, two carriers of a heterochromatic variant on one of the three chromosomes 1, 9 or 16 each were selected. pod-FISH sets as well as single probes for the corresponding three chromosomes were applied. Thus, the chromosome-specific pod-FISH intensity pattern could be correlated with the cytogenetic distinguishable homologous chromosomes. We analyzed 10-25 metaphase spreads per hybridization and found the identical, distinguishable hybridization pattern on the chromosomes with and without the heteromorphism, respectively (Fig. 2) .
In order to obtain a cut-off value for differentiation between real polymorphisms and methodically caused variations within one hybridization we selected two commercially available probes (LSI SYT, 18q11.2, Abbott and LSI ABL, Abbott) and two BAC clones (RP11-358M9 and RP11-175A7) that were not located in known CNP/LCV regions. Twenty metaphase spreads per hybridization were analyzed in lymphocytes from two clinically healthy persons and one in bone marrow from a leukemia patient. Additionally, lymphocytes of a rare case of complete paternal isodisomy in 97% of blood cells was used with the above mentioned probes labeled in two different fluorochromes (Spectrum Orange or Spectrum Green) to uncover the influences of the labeling on the FISH result. In fact no microscopically visible differences were detected between the homologous chromosomes in all analyzed metaphase spreads applying the two different fluorochromes in all probands. Nevertheless, employing the sensitive SCION software we were able to measure the intensity and area of the signals on both homologous chromosomes; the more intense signal was defined as 100%. The mean value of the second signal relative to the reference signal was not <73-90% for both commercially available probes and not <74-80% for the BAC probes (Fig. 4) . Therefore, we concluded that the normal variation of the FISH method for signal identity on both homologous chromosomes for a non-polymorphic region is between 10 and 36%. Thus, if in the polymorphic region the difference was >36%, a real polymorphism distinguishing both homologous chromosomes was suggested. The aforementioned experiments also demonstrated the high sensitivity of the SCION software to measure differences not visible to the naked eye (Fig. 4) .
pod-FISH in UPD analysis. Imprinting of genes can cause specific syndromes when certain chromosomes are inherited from one parent only. Associated with a clinical phenotype are paternal UPD 6, maternal UPD 7, paternal UPD 11, maternal UPD 16 and maternal as well as paternal UPD 14 and 15 (reviewed in ref. 26). As described above, UPD can be investigated by microsatellite analysis of the parents and the child to determine if one parent transferred both alleles and or homologous chromosomes to the child. Therefore, we applied the pod-FISH set for chromosome 15 to a UPD case, unaware of which parent the chromosomes were inherited from, and compared the pod-FISH pattern of the parents and the child. We were able to confirm the molecular genetic microsatellite results on chromosomes investigated with pod-FISH. An example of a UPD 15 confirmation is shown in Fig. 7 . It was clearly demonstrated that none of the signal patterns of the father were found in the child which could also be interpreted as non-paternity, but both pod-FISH patterns of the mother fit exactly to the child confirming the previously found maternal heterodisomy 15 in the child. Moreover, UPD was previously determined by microsatellite analysis (data not shown).
pod-FISH compared to microsatellite analysis. As in the well-established microsatellite analysis, the use of pod-FISH similarly can result in so-called 'non-informative' findings. This shows that the same polymorphic region on both homologous chromosomes can have the identical size and therefore are undistinguishable by the applied approach. However, there are no reports or statistics concerning the genome-wide heterozygosity frequency and/or informative situation in UPD testing by microsatellites.
In order to obtain such a dataset with which to compare the rate of informativeness of pod-FISH, the results of 177 UPD analyses by microsatellite performed in Caucasians were collected in Fig. 6 . Data for all chromosomes were available apart from chromosomes 3 and Y. In summary, 1545 microsatellite PCRs on the basis of 299 different microsatellite probes resulted in 727 (47.1%) non-informative versus 818 (52.9%) informative findings (Fig. 6 ) that allowed a distinctive differentiation of alleles in a parent-child-trio. Therefore, approximately every second microsatellite leads to an informative situation. After evaluation of five healthy control persons for pod-FISH sets of chromosomes 1 to 6 (in summary 53 different probes in 30 experiments) a comparable rate of informativeness was observed in 20-60% of the analyzed chromosomes. In 50% of all chromosomespecific pod-FISH sets, signal intensity differences were observed (Table II) . Nevertheless, a higher degree of informative LCV/CNP loci is needed to result in less noninformative situations. This can be achieved by inclusion of more BAC probes specific for other polymorphic loci in chromosome-specific pod-FISH sets. Information enabling this will be available by published CNP/LCV as more and more studies are performed studying individuals for allele Figure 7 . pod-FISH confirmation of a maternal heterodisomy 15. Comparison of the signal patterns from homologous chromosomes 15 (left to right: inverted DAPI, FITC, Spectrum Orange, Texas Red, Cy5 and DEAC) of the father (A), the mother (B), and the child (C). None of the fluorochrome compositions on both chromosomes 15 from the father fit those of the child. Yet, both fluorochrome patterns of the mother fit those of the child. *The spectrum green-labeled BAC clone RP11-138C5 in 15q11.1 that exemplifies the feasibility for interphase analysis (rightmost panels). Table II . Summarized results of informative situations in relation to the number of used BACs (i./n. BACs) in the 5 subjects tested for chromosomes 1 to 6. ----------------------------------------------------------------------------------------------------- a Differentiation of homologous chromosomes was possible for between 20 and 60% informative situations for different chromosomes and in 50% of all chromosome-specific pod-FISH sets.
-- --------------------------------------------------------------------------------------------- ------frequency estimations and de novo mutation rates. Currently we are working on a genome-wide high frequency CNP/LCV set with population incidences >20% based mainly on recent reports from the 270 Hap map individuals (19, 20) .
Future applications. pod-FISH opens a wide range of possibilites for new fields in research and diagnostics. In this study we made a first approach towards the evaluation of pod-FISH and new diagnostic areas like UPD analysis on metaphase spreads. Potential areas of use include the exclusion of maternal contamination in prenatal diagnosis, detection of chromosome homozygosity processes (e.g. in tumor genesis or aging), the determination of the origin of aberrant chromosomes, the determination of cell mixtures or mosaics (e.g. in clinical monitoring of leukemia patients), proof of paternity by chromosomes and following single chromosomes in generations by pod-FISH.
Microsatellite or SNP approaches are the method of choice to distinguish genomic DNA on a molecular level, but they are unable to determine which allele belongs to which homologous chromosome. Therefore, pod-FISH is the only method able to answer these questions. Furthermore, for molecular approaches, DNA is isolated from a number of cells that can differ in their genomic content, e.g. in cases of mosaicism. In contrast, pod-FISH analyzes single cells where mosaicism can easily be uncovered and interpreted. This can play a significant role, for instance, in AML cases where segmental UPDs were reported for chromosomes 6, 9, 10, 11, 12, 13, 15, 16, 19 and 21 that could only be detected by SNP arrays when the tumor cell fraction was >70% (27) (28) (29) (30) (31) . Inferentially, all AMLs with a lower portion of tumor cells are not analyzable by this method although these epigenetic changes can importantly be used as tumor markers.
In conclusion, pod-FISH is the first cytogenetic method to distinguish homologous chromosomes or sequences based on submicroscopic DNA polymorphisms. The main advantage of this new technique is its performance on single cells. Furthermore, it is suitable for every chromosome. With an expected growing number of reported CNP/LCV a more dense genome-wide coverage will be achieved and more information will be available concerning single frequencies.
